Representatives of the Center took part in an international conference on the global harmonization of approaches to conducting and evaluating bioavailability and bioequivalence studies (3-rd conference on Global Bioequivalence Harmonisation Initiative), held on April 12-13, 2018, in Amsterdam, the Netherlands.
The conference was held on the initiative of the European Federation for Pharmaceutical Sciences (EUFEPS) with the support of the European Medicines Agency (EMA) and the Food and Drug Administration (FDA).
Within the framework of the conference, considerable attention was paid to the approaches to bioequivalence studies that differ among regulatory agencies around the world (Europe, USA, Canada, Japan). During the conference, open discussions and a constructive exchange took place among regulatory authorities, scientists, researchers, and manufacturers of medicinal products. The information obtained makes it possible to understand the prospects for the development of approaches to bioequivalence studies worldwide.
